跳至主要内容
临床试验/NCT05054504
NCT05054504已完成不适用

Integration of Butterfly iQ Point of Care Ultrasound Into Antenatal Care in Blantyre, Malawi: A Feasibility and Acceptability Study

Jhpiego1 个研究点 分布在 1 个国家目标入组 1,575 人开始时间: 2021年10月6日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
Jhpiego
入组人数
1,575
试验地点
1
主要终点
Feasibility of the intervention by participant report

研究概览

简要总结

The purpose of this study is to investigate feasibility and acceptability of a novel intervention to integrate Butterfly IQ into antenatal care (ANC) service delivery in Malawi. The study will also explore potential impact of the intervention on selected service delivery outcomes and identification of abnormal pregnancies.

详细描述

The purpose of this study is to investigate the feasibility and acceptability of a novel intervention to integrate Butterfly IQ into ANC service delivery in Blantyre, Malawi. This study will further the understanding of antenatal ultrasound in Malawi by testing the following hypothesis:

When planned and implemented collaboratively with local stakeholders, limited introduction and integration of point-of-care ultrasound with Butterfly iQ into ANC service delivery at health center level will be feasible and acceptable for health providers and clients.

The study intervention will include a multi-phased approach to design, introduction, improvement, and evaluation of Butterfly IQ for routine obstetric ultrasound integrated into ANC service delivery in Malawi.

Phase 1: Training Phase 1 includes training on Butterfly IQ, integration in ANC workflow, and referral/counter-referral within network.

Phase 2: Iterative Service Delivery Phase 2 includes weekly evaluation and iterative re-design of services.

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Single Group
主要目的
Health Services Research
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Eligibility criteria by phase and participant type
  • Phase 1 Inclusion Criteria
  • Member of HC or hospital staff providing obstetric care.
  • Able and willing to comply with all study requirements and complete all study procedures.
  • Able and willing to provide informed consent to be screened for and to take part in the study.

排除标准

  • Has any condition that, in the opinion of the investigator/designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
  • Phase 2 Inclusion Criteria
  • Study Participant - Health Center and Hospital Staff:
  • Member of HC or hospital staff providing obstetric care.
  • Able and willing to comply with all study requirements and complete all study procedures.
  • Able and willing to provide informed consent to be screened for and to take part in the study.
  • Study Participant - ANC Clients:
  • Participants must meet all criteria to be eligible for inclusion in the study:
  • Age 18 years or older at Screening, as verified per site Standard Operating Procedures (SOPs).
  • At enrollment, present for first ANC visit.
  • Able and willing to comply with all study requirements and complete all Phase 2 study procedures.
  • Able and willing to provide informed consent to be screened for and to take part in Phase 2 of the study.
  • Intention to stay within study catchment area for study Phase 2 duration and willingness to give adequate locator information, as defined in site SOPs.
  • Phase 2 Exclusion Criteria
  • Study Participant - Health Center and Hospital Staff:
  • 1. Has any condition that, in the opinion of the investigator/designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives.
  • Study participant - ANC Clients:
  • 1. Has any condition that, in the opinion of the investigator/designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives
  • Phase 3 Inclusion Criteria
  • Participated in Phase 1 or 2 of the study or newly recruited stakeholder interested in development or implementation of obstetric ultrasound in Malawi.
  • Able and willing to comply with all study requirements and complete all Phase 3 study procedures.
  • Able and willing to provide informed consent to be screened for and to take part in Phase 3 of the study.
  • Phase 3 Exclusion Criteria
  • 1. Has any condition that, in the opinion of the investigator/designee, would preclude informed consent, make study participation unsafe, complicate interpretation of study outcome data, or otherwise interfere with achieving the study objectives

结局指标

主要结局

Feasibility of the intervention by participant report

时间窗: 7 months

Proportion of enrolled midwives who report the intervention to be feasible

Feasibility of the intervention by quality standards met (ultrasound)

时间窗: 7 months

Proportion of ultrasound examinations found to meet quality standards

Feasibility of the intervention by observation of functioning systems

时间窗: 7 months

Proportion of Butterfly IQ systems functioning at end of study period

Feasibility of the intervention by observation of environments of care

时间窗: 7 months

Proportion of participating HC with facilitative environments of care

Feasibility of the intervention by quality standards met (ANC)

时间窗: 7 months

Proportion of ANC visits (that included Butterfly IQ) found to meet quality standards

次要结局

  • Acceptability, by participant report (providers)(7 months)
  • Acceptability, by participant report (ANC clients)(7 months)

研究者

发起方
Jhpiego
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验